Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$76.22 - $98.51 $1,448 - $1,871
-19 Reduced 0.27%
7,053 $680,000
Q3 2023

Nov 09, 2023

SELL
$85.07 - $94.48 $141,046 - $156,647
-1,658 Reduced 18.99%
7,072 $625,000
Q2 2023

Aug 14, 2023

SELL
$86.68 - $100.3 $8,147 - $9,428
-94 Reduced 1.07%
8,730 $756,000
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $122,397 - $163,591
1,395 Added 18.78%
8,824 $858,000
Q4 2022

Feb 08, 2023

BUY
$80.93 - $108.63 $291,267 - $390,959
3,599 Added 93.97%
7,429 $768,000
Q3 2022

Nov 14, 2022

SELL
$82.16 - $96.94 $1.01 Million - $1.19 Million
-12,293 Reduced 76.25%
3,830 $325,000
Q2 2022

Aug 12, 2022

SELL
$71.48 - $86.85 $479,487 - $582,589
-6,708 Reduced 29.38%
16,123 $1.34 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $219,274 - $273,620
2,952 Added 14.85%
22,831 $1.76 Million
Q4 2021

Feb 11, 2022

SELL
$71.72 - $91.47 $49,558 - $63,205
-691 Reduced 3.36%
19,879 $1.76 Million
Q3 2021

Nov 10, 2021

BUY
$74.77 - $85.47 $1.54 Million - $1.76 Million
20,570 New
20,570 $1.59 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.